Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-18-006125
Filing Date
2018-05-14
Accepted
2018-05-14 16:46:56
Documents
4
Effectiveness Date
2018-05-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82018_relmadatherap.htm S-8 83897
2 OPINION OF FENNEMORE CRAIG, P.C fs82018ex5-1_relmada.htm EX-5.1 10113
3 CONSENT OF GBH CPAS, PC fs82018ex23-1_relmada.htm EX-23.1 2173
4 GRAPHIC ex5-1_001.jpg GRAPHIC 9534
  Complete submission text file 0001213900-18-006125.txt   110528
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 646-677-3853
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-224920 | Film No.: 18831408
SIC: 2834 Pharmaceutical Preparations